Piramal Pharma share price: Shares of Piramal Pharma jumped 7.35% in today's trading session to reach a new 52-week high of ₹153.90 apiece. With this, the stock reached its highest level in 18 months. It finished the last six out of seven weeks in green and has gained 32% in the past seven weeks.
The stock is yet to surpass its IPO price of ₹200, which hasn't been achieved since its listing in October 2022. Currently, it remains 24% below the issue price.
Piramal Pharma Limited (PPL) is part of the Piramal Group of Companies which was demerged from Piramal Enterprises. The company's portfolio includes differentiated products and services through its 17 global development and manufacturing facilities and a global distribution network.
It operates in over 100 countries through three major segments: contract development and manufacturing organisations (CDMO), Complex hospital generics (critical care), and consumer healthcare (OTC).
Brokerage firm Jefferies in March recommended a 'buy' rating on the stock, anticipating revenue growth for the financial year 2025 (FY25). It set a target price of ₹170 per share and projected a year-on-year revenue growth of 12.5% for FY25 for Piramal Pharma.
{{/usCountry}}
{{#usCountry}}
Brokerage firm Jefferies in March recommended a 'buy' rating on the stock, anticipating revenue growth for the financial year 2025 (FY25). It set a target price of ₹170 per share and projected a year-on-year revenue growth of 12.5% for FY25 for Piramal Pharma.
Follow the latest breaking news, major developments and agenda-setting stories from India and around the world with the newsdesk at Hindustan Times. Operating round the clock, the desk brings together experienced editors, reporters and correspondents to deliver fast, accurate and contextual reporting across subjects that influence public policy, governance, business, society and international affairs. The HT News Desk covers politics, elections, government policies, the economy, business and markets, science and technology, the environment, law and order, infrastructure, education, climate issues and geopolitics, while closely tracking developments across states, institutions and global capitals. The team also leads coverage of major breaking news events, policy announcements, court proceedings, natural disasters, public emergencies and significant international developments. Reports published by the newsdesk are based on information gathered from reporters on the ground, official statements, government agencies, court records, regulatory filings, recognised institutions and other authoritative sources. Stories undergo editorial scrutiny and verification processes to ensure accuracy, fairness and relevance, and are updated as events evolve and additional information becomes available. Whether covering a key political decision in New Delhi, an economic policy shift affecting millions, a landmark court ruling or a major global event, the HT News Desk aims to provide readers with reliable, fact-based journalism that delivers not only the latest developments but also the context and analysis needed to understand their wider implications.
Stay updated with the latest Business News, stock market updates, petrol and diesel prices, gold and silver rates, income tax updates and major developments from India and across the world.
Stay updated with the latest Business News, stock market updates, petrol and diesel prices, gold and silver rates, income tax updates and major developments from India and across the world.
Home/Business/Piramal Pharma share price rises over 7% to hit 18-month high. Here's why
{{^htLoading}}
Advertisement
{{/htLoading}}
SHARE THIS ARTICLE ON
{{#usCountry}}{{/usCountry}}
Hindustantimes wants to start sending you push notifications. Click allow to subscribe
